Kate George, Editor

About the Author Kate George, Editor


Brean Capital Downgrades Medivation Inc (MDVN) in Wake of Pfizer Merger Agreement

Pfizer will acquire Medivation for $81.50 per share in cash- an offer unlikely to be bested, says Brean Capital

Jefferies Weighs in on Caterpillar Inc. (CAT) Following Meeting with Management

Analyst Stephen Volkmann of Jefferies discussed Caterpillar Inc. (NYSE:CAT) after recently hosting investors for a plant tour and management meetings in Peoria, IL.

Analyst Bullish Towards Cirrus Logic, Inc. (CRUS)

Analyst Rajvindra Gill of Needham & Company reiterated his Buy rating on Cirrus Logic, Inc. (NASDAQ:CRUS) with a price target of $55, marking …

Top Analyst Lifts Price Target for Qorvo Inc (QRVO) Following Solid Quarterly Earnings Report

Canaccord analyst Michael Walkley weighs in on shares of Qorvo Inc (NASDAQ:QRVO) after the wireless chip maker released its fiscal first-quarter results, posting revenues of …

Broker Roundup: Apple Inc. (AAPL), Amazon.com, Inc. (AMZN), Expedia Inc (EXPE), Alphabet Inc (GOOGL)

US stocks are mostly higher in afternoon trading Friday, as investors worked through another mixed batch of corporate earnings. Among the equities in focus today …

RBC Capital Shines Light on Expedia Inc’s (EXPE) 2Q Earnings

Expedia Inc (NASDAQ:EXPE) shares are down nearly 3% to $116.15, after the online travel booking giant reported mixed second-qaurter results, with lower-than-expected revenue but higher EPS …

Roth Capital Weighs In Glu Mobile Inc. (GLUU) Ahead of Upcoming Earnings

Roth Capital analyst Darren Aftahi weighs in on Glu Mobile Inc. (NASDAQ:GLUU) ahead of the company’s second-quarter earnings report on Tuesday, August 2.

Baird Analyst Worries About Slowing Demand For Fitbit Inc (FIT); Here’s Why

Analyst William Power from Robert W. Baird maintained his Neutral rating on Fitbit Inc (NYSE:FIT) with a price target of $16, marking a 23% …

All Eyes on Relypsa Inc (RLYP) Acquisition; Brean Capital Sees the Offer Price as Reasonable

Galenica AG, specialty pharma giant owning Switzerland’s largest pharmacy network, is set to add drug-maker Relypsa Inc (NASDAQ:RLYP) to its beefed-up network, gaining …